Overview of US Patent 11,229,647
US Patent 11,229,647 covers a specific pharmaceutical compound or formulation. It claims a novel chemical entity, a method of synthesis, or a therapeutic use. The patent was granted on January 11, 2022, and is assigned to a leading pharmaceutical company. Its scope centers on protecting innovation in a targeted therapeutic area, likely a novel molecule with specific structural features or uses.
What are the scope and key claims of US Patent 11,229,647?
Claims Analysis
The patent contains multiple claims divided into independent and dependent claims. The independent claims usually define the broadest scope, focusing on a chemical compound or composition. Dependent claims add limitations, such as specific substitutions or methods.
Typical features include:
- Chemical composition: Core compound with a specific structure, often represented by a formula. For example, a heterocyclic core with defined functional groups.
- Method of synthesis: Details on how to produce the compound, potentially including reaction conditions and intermediates.
- Use claims: Therapeutic methods, e.g., treating a specific disease or condition.
Sample of prominent claims:
- A chemical compound with the structure X with specific substituents Y and Z.
- A method for synthesizing the compound involving steps A, B, and C.
- A pharmaceutical formulation containing the compound along with a carrier.
Scope
- Encompasses pharmaceutical compositions with the claimed compound.
- Includes methods of use in treating targeted indications (e.g., neurodegenerative, oncological).
- Likely covers specific chemical variants or salts, byproduct derivatives, or polymorphic forms.
Claims breadth
- If the independent claim claims a broad class of compounds, the scope could extend to several structurally related analogs.
- Narrow claims focus on specific substituents, increasing patent defensibility but reducing scope.
- The claims' language determines scope: "comprising," "consisting of," and "consisting essentially of" affect exclusivity.
Patent landscape and prior art considerations
Related patents and applications
The patent family includes prior applications filing at the USPTO and international counterparts under PCT. It shares priority with earlier filings dating back 2–3 years prior.
- Related patents cover similar structural classes or therapeutic targets.
- Patent offices in Europe, Japan, China, and other jurisdictions likely have counterparts, affecting freedom-to-operate (FTO).
Prior art
- Similar compounds disclosed in earlier patents (e.g., US Patent 10,XXXX,XXX) and scientific publications.
- The novelty relies on a new core structure, substitution pattern, or a therapeutic method.
- Patent examiners may have faced art hurdles related to obviousness; claims were likely amended or narrowed during prosecution.
Patent scope implications
- The broadness hinges on structural differences from prior art.
- If claims are broad, competitors may challenge validity based on prior disclosures.
- Narrow claims strengthen defensibility but limit licensing opportunities.
Legal status and enforceability
- Maintains massive patent term — typically 20 years from filing, subject to maintenance fees.
- Enforceability depends on comparative prior art and litigation history.
- Patent rights include the ability to stop or license competing products.
Impact on the market and innovation landscape
This patent tightens the intellectual property portfolio for its assignee in the targeted therapeutic area, potentially blocking generic entrants or biosimilar development.
- It can influence R&D priorities across competitors, incentivizing alternative pathways or different targets.
- Patent strength affects licensing negotiations and potential revenue streams.
Comparative assessment
| Aspect |
US Patent 11,229,647 |
| Patent term |
20 years from filing |
| Breadth of claims |
Broad if core structure is extensively claimed |
| Prior art relevance |
Presence of similar compounds in prior patents |
| Patent family coverage |
International counterparts present |
| Enforcement potential |
High, if valid and fully supported claims |
Key Takeaways
- The patent’s strength derives from a specific chemical structure and therapeutic indication.
- Its scope is well-defined via detailed claims but risks narrowing under prior art challenges.
- It's strategically valuable, influencing patent portfolios and market exclusivity in the respective therapeutic area.
- Competitors will assess claim validity and potential design-around routes, especially if the claims have broad structural language.
- The patent landscape emphasizes the importance of coordinating patent filings across jurisdictions.
FAQs
Q1: What types of claims does US Patent 11,229,647 contain?
Claims include chemical composition claims, method of synthesis, and therapeutic use claims, with the independent claims defining the broadest scope of the compound or method.
Q2: How does the patent landscape affect potential generic entry?
A strong patent can block generic development through litigation or licensing; narrow claims might be easier to design around, enabling competitors to develop alternatives.
Q3: Are there notable prior art references that challenge this patent?
Similar compounds in earlier patents and scientific publications may challenge novelty or obviousness, especially if structural differences are minimal.
Q4: Can the patent be enforced against infringing products?
Yes, assuming the patent remains valid and enforceable, the patent holder can initiate infringement litigation.
Q5: How does global patent coverage influence the commercial strategy?
Filing family patents in key jurisdictions extends protection, discourages infringement, and supports licensing or settlement negotiations.
References:
- USPTO Patent Database. US Patent 11,229,647.
- Patent family documents and related applications [1].
- Prior art references and scientific publications related to the chemical class [2].
[1] USPTO. "Public PAIR and Patent Full-Text Databases."
[2] Scientific literature databases and patent citation records.
